• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童期原发性骨质疏松症的新基因形式

New Genetic Forms of Childhood-Onset Primary Osteoporosis.

作者信息

Kämpe Anders J, Mäkitie Riikka E, Mäkitie Outi

机构信息

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

出版信息

Horm Res Paediatr. 2015;84(6):361-9. doi: 10.1159/000439566. Epub 2015 Oct 31.

DOI:10.1159/000439566
PMID:26517534
Abstract

Recent developments in genetic technology have given us the opportunity to look at diseases in a new and more detailed way. This Mini Review discusses monogenetic forms of childhood-onset primary osteoporosis, with the main focus on osteoporosis caused by mutations in WNT1 and PLS3, two of the most recently discovered genes underlying early-onset osteoporosis. The importance of WNT1 in the accrual and maintenance of bone mass through activation of canonical WNT signaling was recognized in 2013. WNT1 was shown to be a key ligand for the WNT-signaling pathway, which is of major importance in the regulation of bone formation. More recently, mutations in PLS3, located on the X chromosome, were shown to be the cause of X-linked childhood-onset primary osteoporosis affecting mainly males. The function of PLS3 in bone metabolism is still not completely understood, but it has been speculated to have an important role in mechanosensing by osteocytes and in matrix mineralization. In this new era of genetics, our knowledge on genetic causes of childhood-onset osteoporosis expands constantly. These discoveries bring new possibilities, but also new challenges. Guidelines are needed to implement this new genetic knowledge to clinical patient care and to guide genetic investigations in affected families.

摘要

基因技术的最新进展使我们有机会以一种全新且更详细的方式看待疾病。本综述讨论儿童期起病的原发性骨质疏松症的单基因形式,主要聚焦于由WNT1和PLS3突变引起的骨质疏松症,这是最近发现的两个早发性骨质疏松症相关基因。2013年,人们认识到WNT1通过激活经典WNT信号通路在骨量积累和维持中的重要性。WNT1被证明是WNT信号通路的关键配体,在骨形成调节中起主要作用。最近,位于X染色体上的PLS3突变被证明是主要影响男性的X连锁儿童期起病的原发性骨质疏松症的病因。PLS3在骨代谢中的功能仍未完全明确,但据推测它在骨细胞的机械传感和基质矿化中起重要作用。在这个遗传学的新时代,我们对儿童期起病骨质疏松症的遗传病因的认识在不断扩展。这些发现带来了新的可能性,但也带来了新的挑战。需要制定指南,将这些新的遗传学知识应用于临床患者护理,并指导对受影响家庭的基因研究。

相似文献

1
New Genetic Forms of Childhood-Onset Primary Osteoporosis.儿童期原发性骨质疏松症的新基因形式
Horm Res Paediatr. 2015;84(6):361-9. doi: 10.1159/000439566. Epub 2015 Oct 31.
2
Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.在由WNT1和PLS3突变引起的低转换型骨质疏松症中,骨细胞蛋白表达发生改变。
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2340-2348. doi: 10.1210/jc.2017-00099.
3
A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis.PLS3基因中的一种新型剪接突变导致X连锁早发性低转换型骨质疏松症。
J Bone Miner Res. 2015 Mar;30(3):510-8. doi: 10.1002/jbmr.2355.
4
Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study.特立帕肽治疗WNT1或PLS3突变相关的早发性骨质疏松症患者:一项试点研究。
J Clin Endocrinol Metab. 2017 Feb 1;102(2):535-544. doi: 10.1210/jc.2016-2423.
5
Recent Discoveries in Monogenic Disorders of Childhood Bone Fragility.儿童单基因骨脆弱性疾病的最新发现。
Curr Osteoporos Rep. 2017 Aug;15(4):303-310. doi: 10.1007/s11914-017-0388-6.
6
PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization.PLS3 缺失导致严重的脊柱骨质疏松症和骨基质矿化紊乱。
J Bone Miner Res. 2017 Dec;32(12):2394-2404. doi: 10.1002/jbmr.3233. Epub 2017 Sep 6.
7
PLS3 mutations in X-linked osteoporosis with fractures.X 连锁低骨量骨折性骨质疏松症中的 PLS3 突变。
N Engl J Med. 2013 Oct 17;369(16):1529-36. doi: 10.1056/NEJMoa1308223. Epub 2013 Oct 2.
8
A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid.一个新的 PLS3 大片段缺失导致罕见的 X 连锁早发性骨质疏松症和唑来膦酸反应。
Osteoporos Int. 2017 Sep;28(9):2691-2700. doi: 10.1007/s00198-017-4094-0. Epub 2017 Jun 16.
9
PLS3 Mutations in X-Linked Osteoporosis: Clinical and Bone Characteristics of Two Novel Mutations.X 连锁低骨量症中的 PLS3 突变:两种新突变的临床和骨骼特征。
Horm Res Paediatr. 2017;88(3-4):298-304. doi: 10.1159/000477242. Epub 2017 Jun 12.
10
Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics.由PLS3基因突变引起的骨质疏松症:临床和骨组织特征
J Bone Miner Res. 2014 Aug;29(8):1805-14. doi: 10.1002/jbmr.2208.

引用本文的文献

1
Idiopathic Juvenile Osteoporosis Diagnosed in Adulthood: The First Documented Case in Georgia.成年期诊断的特发性青少年骨质疏松症:佐治亚州首例有记录的病例。
Cureus. 2025 May 8;17(5):e83707. doi: 10.7759/cureus.83707. eCollection 2025 May.
2
Osteoporotic Burst Fracture in a Young Male Adult as First Presentation of a Rare PLS3 Mutation: A Case Report.一名年轻男性成人首次出现骨质疏松性爆裂骨折,系罕见的PLS3基因突变所致:病例报告
Cureus. 2023 Dec 29;15(12):e51264. doi: 10.7759/cureus.51264. eCollection 2023 Dec.
3
Medical Care Use Among Patients with Monogenic Osteoporosis Due to Rare Variants in LRP5, PLS3, or WNT1.
患有 LRP5、PLS3 或 WNT1 罕见变异所致单基因骨质疏松症患者的医疗保健利用情况。
Calcif Tissue Int. 2023 Aug;113(2):186-194. doi: 10.1007/s00223-023-01101-3. Epub 2023 Jun 6.
4
Case report: Early-onset osteoporosis in a patient carrying a novel heterozygous variant of the gene.病例报告:携带基因新型杂合变异的患者出现早发性骨质疏松症。
Front Endocrinol (Lausanne). 2022 Aug 8;13:918682. doi: 10.3389/fendo.2022.918682. eCollection 2022.
5
Advances in Diagnosis and Management of Childhood Osteoporosis.儿童骨质疏松症的诊断与治疗进展。
J Clin Res Pediatr Endocrinol. 2022 Dec 1;14(4):370-384. doi: 10.4274/jcrpe.galenos.2022.2022-8-3. Epub 2022 Aug 19.
6
Early-Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen.早发性骨质疏松症:罕见的单基因形式阐明了 I 型胶原以外的疾病发病机制的复杂性。
J Bone Miner Res. 2022 Sep;37(9):1623-1641. doi: 10.1002/jbmr.4668. Epub 2022 Sep 11.
7
Osteoporosis in children and adolescents: when to suspect and how to diagnose it.儿童和青少年骨质疏松症:何时怀疑,如何诊断。
Eur J Pediatr. 2022 Jul;181(7):2549-2561. doi: 10.1007/s00431-022-04455-2. Epub 2022 Apr 6.
8
Diagnostic yield of bone fragility gene panel sequencing in children and young adults referred for idiopathic primary osteoporosis at a single regional reference centre.在一个地区参考中心,针对因特发性原发性骨质疏松症前来就诊的儿童和青年进行骨脆性基因检测板测序的诊断率。
Bone Rep. 2022 Feb 23;16:101176. doi: 10.1016/j.bonr.2022.101176. eCollection 2022 Jun.
9
Drug Treatment of Low Bone Mass and Other Bone Conditions in Pediatric Patients.儿科患者低骨量及其他骨骼疾病的药物治疗
Paediatr Drugs. 2022 Mar;24(2):103-119. doi: 10.1007/s40272-021-00487-7. Epub 2022 Jan 11.
10
Plastin 3 in health and disease: a matter of balance.Plastin 3 在健康和疾病中的作用:平衡的问题。
Cell Mol Life Sci. 2021 Jul;78(13):5275-5301. doi: 10.1007/s00018-021-03843-5. Epub 2021 May 23.